InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
4
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-12.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Black Jeffrey G., 首席财务官. Director active across 4 companies, notably EXAGEN INC.. In total, 17 filings have been logged. Breakdown: 4 buys · 2 sells. Total volume traded: €589k. Activity tracked since 11 August 2021. The latest transaction was filed on 12 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Black Jeffrey G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
75,000 股@ US$3.1646.1% 占其流量Common StockSEC:0001449439-26-000005:0
1,584 股@ US$3.610.0055% mcap1.4% 占其流量Common StockSEC:0001449439-26-000003:0
20,466 股@ US$9.790.20% mcap48.6% 占其流量Common StockSEC:0001628280-25-041688:0
15,000 股0Common StockSEC:0001274737-25-000011:0
22,298 股@ US$2.9815.1% 占其流量Common StockSEC:0001274737-24-000096:0
标准退出：2025年2月13日 (T+90)
6,690 股@ US$1.9111.4% 占其流量Common StockSEC:0000950170-24-104133:0
225,000 股0Common StockSEC:0001274737-24-000084:0
13,157 股0Common StockSEC:0000950170-24-098700:0
300,000 股0Common StockSEC:0000950170-24-063094:0
52,631 股0Common StockSEC:0000950170-24-061315:0
43,492 股@ US$2.215788.6% 占其流量Common StockSEC:0001162194-23-000030:0
标准退出：2023年8月16日 (T+90)
335,330 股Common StockSEC:0001251769-23-000022:0
15,060 股@ US$6.4617.1% 占其流量Common StockSEC:0001251769-22-000085:0
6,190 股@ US$6.466.7% 占其流量Common StockSEC:0001251769-22-000074:0
88,900 股0Common StockSEC:0001251769-22-000055:0
15,000 股@ US$5.4816.5% 占其流量Common StockSEC:0001251769-22-000020:0
标准退出：2022年5月26日 (T+90)
25,000 股@ US$8.7546.7% 占其流量Common StockSEC:0001251769-21-000103:0
标准退出：2021年11月9日 (T+90)
17 条申报中的 17 条
About Black Jeffrey G.
Jeffrey G. Black is the Chief Financial Officer of Exagen Inc. and Apollo Endosurgery, Inc. He is responsible for the financial management of these companies, including budget planning and financial performance analysis. His role is essential in ensuring the profitability and growth of these organizations. Jeffrey works closely with other executives to align financial and strategic objectives.
